Pharmacotherapeutic Study of Maharasona with Reference to Tamaka Shwasa
Tamaka Shwasa is considered to be a dreadful disease as it is yapya (hard to treat) and ashuprananashakari (destroys the life very fast) and has high prevalence in society and presents in vegas (attacks) and dyspnoea as its cardinal symptom. Ayurveda describes detailed line of treatment for Tamaka shwasa which includes shodhana, shamana, and brihana for apunarbhava. Shamana dravyas indicated in tamaka shwasa should be kaphavatashamaka, amapachana and anulomana. Maharasona is a dravya possessing katu madhur pradhan pancharasa, teekshna-ushna guna ushnaveerya, katuvipaka and vatakaphahara. Total 30 patients of Tamaka shwasa were selected as per inclusion criteria and treated with Maharasona (Allium porrum Lambinon et al.) Kalka 3 grams twice a day before meals with water. Incidence of agnimandya and kasa was observed very much associated with shwasa and kujanadhwani as its cardinal symptom. Maharasona kalka showed significant improvement in symptoms like shwasakruchrata, agnimandya, kaphanishtheevana, jwara and peenasa. This improvement may be due to its above said gunas. Hence, from this study, it can be concluded that Maharasona is effective and can be safely used in the management of Tamaka Shwasa.
Copyright (c) 2020 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.